Early-stage loss of dopamine uptake-site binding in MPTP-treated monkeys
Graybiel, A.M.; Moratalla, R.; Quinn, B.; DeLanney, L.E.; Irwin, I.; Langston, J.W.
Advances in Neurology 60: 34-39
1993
ISSN/ISBN: 0091-3952 PMID: 8420148 Document Number: 408681
Document emailed within 1 workday
Related Documents
Luquin, M.R.; Guillén, J.; Legarda, I.; Cruz Rodriguez, M.; Del Rio, L.; Dominguez, J.; Martínez-Lage, J.M. 1996: Pulsatile administration of D1 but not D2 dopamine agonists induces behavioral tolerance in MPTP-treated monkeys Advances in Neurology 69: 239-244Domino, E.F.; Sheng, J. 1993: Relative potency and efficacy of some dopamine agonists with varying selectivities for D1 and D2 receptors in MPTP-induced hemiparkinsonian monkeys Journal of Pharmacology and Experimental Therapeutics 265(3): 1387-1391
Wagner, G.C.; Ricaurte, G.A.; Johanson, C.E.; Schuster, C.R.; Seiden, L.S. 1980: Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate Neurology 30(5): 547-550
Szczudlik, A.; Rudzińska, M. 2007: Are dopamine agonists alternative therapy for levodopa in early stage of Parkinson's disease? Yes Neurologia i Neurochirurgia Polska 41(2 Suppl 1: S6-S9
Zhou, J.; Duan, L.-p.; Yang, X.-l.; Dong, X.-y.; Lin, S.-r. 2003: The roles of dopamine 4 receptor in MPTP-induced gastrointestinal mucosal injury in rats Zhonghua Yi Xue Za Zhi 83(18): 1611-1614
Levitskaia, N.G.; Sebentsova, E.A.; Andreeva, L.A.; Alfeeva, L.I.; Kamenskiĭ, A.A.; Miasoedov, N.F. 2002: Neuroprotective effects of semax in MPTP-induced disturbances of brain dopamine system Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 88(11): 1369-1377
Fuller, R.W.; Hemrick-Luecke, S.K. 1987: Persistent depletion of striatal dopamine and its metabolites in mice by TMMP, an analogue of MPTP Journal of Pharmacy and Pharmacology 39(8): 667-669
Nie, J.C.; Chen, G.H.; Yan, A.Q.; Liu, X.S. 2017: Placental site trophoblastic tumor in early stage: a case report European Journal of Gynaecological Oncology 38(3): 479-481
Chen, S.D.; Zhou, X.D.; Xu, D.L.; Li, G.W.; Tang, Q.M.; Xu, X.R. 1991: Hemiparkinsonism in monkeys following unilateral common carotid artery infusion of MPTP. a study of behavior, biochemistry and histology Chinese Medical Journal 104(9): 758-763
Wustmann, C.; Rudolph, E.; Schwipper, U.; Ranacher, B.; Fischer, H.D.; Schmidt, J. 1982: Effect of nootropic drugs on the dopamine release and dopamine uptake in structures of the rat striatum Acta Biologica et Medica Germanica 41(6): 575-579
Morelli, A.; Narducci, F.; Camardella, G.; Pelli, M.A.; Floridi, A.; Nenci, G.G. 1977: Dopamine uptake by platelets in hepatic encephalopathy; evidence for a possible depletion of brain dopamine Acta Hepato-Gastroenterologica 24(6): 405-410
Blanchet, P.J.; Gomez-Mancilla, B.; Bédard, P.J. 1995: DOPA-induced "peak dose" dyskinesia: clues implicating D2 receptor-mediated mechanisms using dopaminergic agonists in MPTP monkeys Journal of Neural Transmission. Supplementum 45: 103-112
Kuczenski, R.; Segal, D.S. 1992: Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine Journal of Pharmacology and Experimental Therapeutics 262(3): 1085-1094
Teng, L.; Crooks, P.A.; Sonsalla, P.K.; Dwoskin, L.P. 1997: Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake Journal of Pharmacology and Experimental Therapeutics 280(3): 1432-1444
Chan, P.; Di Monte, D.A.; Langston, J.W.; Janson, A.M. 1997: (+)MK-801 does not prevent MPTP-induced loss of nigral neurons in mice Journal of Pharmacology and Experimental Therapeutics 280(1): 439-446
Nunomura, W.; Hatakeyama, M. 1990: Binding of low density lipoprotein (LDL) to C-reactive protein (CRP): a possible binding through apolipoprotein B in LDL at phosphorylcholine-binding site of CRP Hokkaido Journal of Medical Science 65(5): 474-480
Davies, S.J.; Ogg, C.S.; Cameron, J.S.; Poston, S.; Noble, W.C. 1989: Staphylococcus aureus nasal carriage, exit-site infection and catheter loss in patients treated with continuous ambulatory peritoneal dialysis (CAPD) Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 9(1): 61-64
Lee, F.J.S.; Liu, F.; Pristupa, Z.B.; Niznik, H.B. 2018: Direct binding and functional coupling of α-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis FASEB Journal 15(6): 916-926
Kozlowski, L.; Filipowski, T.; Rucinska, M.; Pepinski, W.; Janica, J.; Skawronska, M.; Poznanski, J.; Wojtukiewicz, M.Z. 2006: Loss of heterozygosity on chromosomes 2p, 3p, 18q21.3 and 11p15.5 as a poor prognostic factor in stage II and III (FIGO) cervical cancer treated by radiotherapy Neoplasma 53(5): 440-443
Hoffmann, I.S.; Talmaciu, R.K.; Cubeddu, L.X. 1986: Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release Journal of Pharmacology and Experimental Therapeutics 238(2): 437-446